• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. DERMABOND PRINEO 42CM MSH 3.8ML ADHESIVE CUTANEOUS TISSUE ADHESIVE WITH MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. DERMABOND PRINEO 42CM MSH 3.8ML ADHESIVE CUTANEOUS TISSUE ADHESIVE WITH MESH Back to Search Results
Catalog Number CLR422
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Itching Sensation (1943); Skin Irritation (2076); Tissue Damage (2104)
Event Date 07/31/2020
Event Type  Injury  
Manufacturer Narrative
Product complaint #: (b)(4). Attempts to obtain the following information have been made however, not received to date. To date the device has not been received. If the further details are received at a later date a supplemental medwatch will be sent. It was noted that rx cream was prescribed, please provide details. Please describe how was the adhesive was applied. What prep was used prior to, during or after prineo use? was a dressing placed over the incision? if so, what type of cover dressing used? is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? is the patient hypersensitive to pressure sensitive adhesives? were any patch or sensitivity tests performed? patient pre-existing medical conditions (ie. Allergies, history of reactions) does the patient use or exposed to similar glues/agents for repair, crafts, cosmetic use (lashes, nails) was prineo/dermabond or skin adhesive used on the patient in a previous surgery or wound closure? additional information received: representative informed that the prineo is being left on the patient for four weeks. The patient did not present with skin reactions until after the prineo was removed. The representatives also stated that the individuals applying the prineo sometimes used their gloved finger tip to spread the adhesive on the mesh. Events reported on mw# 2210968-2020-06408. If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Event Description
It was reported a patient underwent a cabg with bilateral lower leg saphenous vein harvest on (b)(6) 2020 and skin adhesive with mesh was used. Dressing removed about 3 weeks post op and patient developed skin irritation, redness, itching and blistering. There was no issue removing the adhesive, it came off easy with no pain or irritation and everything looked fine initially. Patient taking benadryl for the rash which is bumpy/itchy and has travelled about 6 inches up towards thighs on both legs. Yellowish drainage, light warmth around incision and the red area (which follows the outline of the adhesive tape) and blisters. It is starting to improve, approximately 2 weeks after removal. Swab of skin blisters came back positive for group b strep patient was prescribed antibiotics and topical cream. Additional information has been requested.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameDERMABOND PRINEO 42CM MSH 3.8ML ADHESIVE
Type of DeviceCUTANEOUS TISSUE ADHESIVE WITH MESH
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
Manufacturer (Section G)
ETHICON INC.-SAN LORENZO PR
road 183, km. 8.3
san lorenzo 00754
00754
Manufacturer Contact
elba bello
p.o. box 151, route 22 west
somerville, NJ 08876
9082183429
MDR Report Key10459292
MDR Text Key210398623
Report Number2210968-2020-06410
Device Sequence Number1
Product Code OMD
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K163645
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation
Type of Report Initial
Report Date 08/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/27/2020
Is this an Adverse Event Report? Yes
Device Operator
Device Catalogue NumberCLR422
Was Device Available for Evaluation? No
Is the Reporter a Health Professional?
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received08/06/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device?
Type of Device Usage Initial

Patient Treatment Data
Date Received: 08/27/2020 Patient Sequence Number: 1
-
-